Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371631 · ClinicalTrials.gov registry record · Phase 1
Colonizing Neurogenic Bladders With Benign Flora
A Phase 1 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT00371631: Completed Phase 1 study, sponsored by US Department of Veterans Affairs.
NCT00371631 is a Phase 1 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 13 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00371631, a Phase 1 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of the research is to determine whether we can get harmless bacteria to live in the bladders of persons with spinal cord injury who practice intermittent bladder catheterization. We will also look at whether having the harmless bacteria in the bladder prevents urinary tract infections from occurring.
Primary Outcome
Bladder colonization was defined when (≥102 cfu/ml) of E. coli 83972 was detected in urine cultures for \> 3 days after catheter removal.
Interventions
- BIOLOGICAL Insertion of urinary catheters coated with E. coli 83972
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-04 |
| Phase | Phase 1 |
What the finished NCT00371631 record still lists
NCT00371631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Insertion of urinary catheters coated with E. coli 83972 is the first listed.
NCT00371631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00371631 about?
NCT00371631 is a clinical study titled "Colonizing Neurogenic Bladders With Benign Flora". The purpose of the research is to determine whether we can get harmless bacteria to live in the bladders of persons with spinal cord injury who practice intermittent bladder catheterization. We will also look at whether having the harmless bacteria in the bladder prevents urinary tract infections fr...
What is the current status of trial NCT00371631?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2006-10. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00371631?
The interventions under investigation include: Insertion of urinary catheters coated with E. coli 83972 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00371631?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00371631's enrollment target sits among peer trials
13 1847th of 2000 higher than 149 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia